COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

COVID-19 Briefings

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

CHANGE Healthcare

Free COVID-19 Business Intelligence and Analysis for our Colleagues in Clinical Laboratories, Pathology Groups and Hospital Administration

Update as of May 6, 2021

Change Healthcare tracked the decline in anatomic pathology test referrals and cash flow beginning in early March as the physicians and hospitals responded to the COVID-19 pandemic. This decline started in early March and continued April and May. Change Healthcare provides Revenue Cycle Management Services for over 300 pathology and laboratory clients nationwide.

Utilizing its extensive database of billing and coding data, Change has been monitoring and trending pathology testing volumes during the COVID-19 pandemic. Below are weekly trends for pathology testing volume for both hospital-based and independent pathology groups. Hospital testing volumes include both inpatient and outpatient services, while the non-hospital services are test requests originating from outside the hospital including physician office and surgery center referrals.

About Change Healthcare
For 40 years, Change Healthcare has been an industry leader in medical billing and accounts receivable management services for pathologists and clinical laboratories. We have developed one of the industry’s most comprehensive revenue cycle management solutions dedicated solely to helping clients optimize revenues, control costs, mitigate regulatory risks, and differentiate themselves in the market. Change Healthcare provides Revenue Cycle Management Services for over 300 pathology and laboratory clients nationwide. Utilizing, our extensive data-base of billing and coding data, Change has been monitoring and trending pathology testing volumes during the COVID-19 pandemic. Learn more at changehealthcare.com.